This business story checked some of our boxes, but fell short on the key criteria that we think readers needed in this discussion of new Alzheimer’s drugs.
A poor-quality news release spawned weak coverage from the CBC, which is paraphrased here by Fox with even less context and nuance. Failure on many levels.
How fast should you run to live longer? This story provides clear answer based on the best available evidence.
The tone of this story is appropriately calibrated to the preliminary nature of the evidence on offer, with good discussion of study limitations.